or
Method and procedure for preparing red blood fractions



Bookmark and Share
PDF+Word+Text
Download of US
Patent 5550060
Bulk Download
of 50+ Related
Patent PDFs
$39.95
Document Number
US Patent 5550060
Issued Date
August 27, 1996
Link
Inventors
Map
Abstract
Methods and apparatus for separating red blood cells by density are described. Older red blood cells are more dense than younger ones. Certain changes in the physiology are recorded in changes in hemoglobin or the red blood cells. By assaying different aged red blood cells, one can determine the historical physiological changes over a period of many weeks. Improved separation of red blood cells is accomplished by using rigid capillary tubes having an inner surface which augments the density equilibrium of red blood cells and/or incrementally increasing the centrifugation forces, as well as by chemically treating red blood cells to improve their deformability.
Drawing
Method and procedure for preparing red blood fractions - US Patent 5550060 Drawing
Drawing from US Patent 5550060
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
24
Comments:
no comments yet
Owner
Chronomed, Inc. (San Carlos, CA)
Published
August 27, 1996
Application Number
08/237,095
Filed
May 3, 1994
US Classification
436/63   210/515 210/516 210/518 422/102 422/72 424/534 427/2.13 436/50 436/531 436/67
Int'l Classification
A61K   35/18   (20060101)   C12N   15/82   (20060101)  
Examiner
Assistant Examiner
Parent Case
The present application is a continuation in part of application Ser. No. 07/970,840, filed Nov. 3, 1992, and now abandoned, the entire contents of which are hereby incorporated by reference.
USPTO Field of Search
436/63   436/67   436/50   436/531   422/72   422/102   422/82.02   422/241   55/386   424/534   210/515   210/516   210/518   210/804   210/651   210/782   427/2  
Related Patents
7438860 - Droplet discharging head and microarray manufacturing method - Owned by Seiko Epson Corporation (JP) Ishihara; Kazuhiko (JP)

It is an object of the present invention to provide a droplet discharging head suited to the discharge of a sample solution, and particularly one that contains a bio-related substance. This object is achieved by a droplet discharging head 1 for discharging a sample solution, wherein the portion of the inner walls of the droplet discharging head 1 that comes into contact with the sample solution is covered with a polymer composed of phosphorylcholine group-containing unsaturated compound units, or a copolymer including same. The droplet discharging head is preferably an electrostatic drive or piezoelectric drive type.

7534618 - Systems and methods for measuring glycated hemoglobin - Owned by Hewlett-Packard Development Company, L.P. (Houston, TX)

Systems and methods for fractionating components of a sample are disclosed herein. A method of fractionating components of a sample includes establishing a solution density gradient in a capillary channel, applying the sample to the capillary channel, and centrifuging the sample in the capillary channel, thereby separating the components of the sample by density.

6340570 - Detection and characterization of microorganisms - Owned by Large Scale Proteomics Corp. (Germantown, MD)

A method for separating microorganisms, especially infectious agents, from a mixture by two dimensional centrifugation on the basis of sedimentation rate and isopycnic banding density, for sedimenting such microorganisms through zones of immobilized reagents to which they are resistant, for detecting banded particles by light scatter or fluorescence using nucleic acid specific dyes, and for recovering the banded particles in very small volumes for characterization by mass spectrometry of viral protein subunits and intact viral particles, and by fluorescence flow cytometric determination of both nucleic acid mass and the masses of fragments produced by restriction enzymes. The method is based on the discovery that individual microorganisms, such as bacterial and viral species, are each physically relatively homogeneous, and are distinguishable in their biophysical properties from other biological particles, and from non-biological particles found in nature. The method is useful for distinguishing infections, for identifying known microorganisms, and for discovering and characterizing new microorganisms. The method provides very rapid identification of microorganisms, and hence allows a rational choice of therapy for identified infectious agents. A particularly useful application is in clinical trials of new antibiotics and antivirals, where it is essential to identify at the outset individuals infected with the targeted infectious agent.

6911312 - Detection and characterization of microorganisms - Owned by Large Scale Proteomics Corporation (Vacaville, CA)

A method for separating microorganisms, especially infectious agents, from a mixture by two dimensional centrifugation on the basis of sedimentation rate and isopycnic banding density, for sedimenting such microorganisms through zones of immobilized reagents to which they are resistant, for detecting banded particles by light scatter or fluorescence using nucleic acid specific dyes, and for recovering the banded particles in very small volumes for characterization by mass spectrometry of viral protein subunits and intact viral particles, and by fluorescence flow cytometric determination of both nucleic acid mass and the masses of fragments produced by restriction enzymes. The method is based on the discovery that individual microorganisms, such as bacterial and viral species, are each physically relatively homogeneous, and are distinguishable in their biophysical properties from other biological particles, and from non-biological particles found in nature. The method is useful for distinguishing infections, for identifying known microorganisms, and for discovering and characterizing new microorganisms. The method provides very rapid identification of microorganisms, and hence allows a rational choice of therapy for identified infectious agents. A particularly useful application is in clinical trials of new antibiotics and antivirals, where it is essential to identify at the outset individuals infected with the targeted infectious agent.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us